[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO881507D0 - Fremgangsmaate for forhoeyning av hematokritnivaaet til et normalt pattedyr. - Google Patents

Fremgangsmaate for forhoeyning av hematokritnivaaet til et normalt pattedyr.

Info

Publication number
NO881507D0
NO881507D0 NO881507A NO881507A NO881507D0 NO 881507 D0 NO881507 D0 NO 881507D0 NO 881507 A NO881507 A NO 881507A NO 881507 A NO881507 A NO 881507A NO 881507 D0 NO881507 D0 NO 881507D0
Authority
NO
Norway
Prior art keywords
increasing
mammal
procedure
hematocrit level
normal mammal
Prior art date
Application number
NO881507A
Other languages
English (en)
Inventor
John F A Vance
Robert I Abels
Original Assignee
Ortho Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21889805&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO881507(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ortho Pharma Corp filed Critical Ortho Pharma Corp
Publication of NO881507D0 publication Critical patent/NO881507D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1816—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Electrotherapy Devices (AREA)
  • Peptides Or Proteins (AREA)
NO881507A 1987-04-10 1988-04-07 Fremgangsmaate for forhoeyning av hematokritnivaaet til et normalt pattedyr. NO881507D0 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3664687A 1987-04-10 1987-04-10

Publications (1)

Publication Number Publication Date
NO881507D0 true NO881507D0 (no) 1988-04-07

Family

ID=21889805

Family Applications (1)

Application Number Title Priority Date Filing Date
NO881507A NO881507D0 (no) 1987-04-10 1988-04-07 Fremgangsmaate for forhoeyning av hematokritnivaaet til et normalt pattedyr.

Country Status (13)

Country Link
US (1) US5541158A (no)
EP (1) EP0286439B1 (no)
JP (1) JP2858752B2 (no)
KR (1) KR880012235A (no)
AT (1) ATE70978T1 (no)
AU (1) AU613905B2 (no)
DE (1) DE3867285D1 (no)
DK (1) DK167903B1 (no)
ES (1) ES2035279T3 (no)
GR (1) GR3004071T3 (no)
IE (1) IE61008B1 (no)
NO (1) NO881507D0 (no)
PT (1) PT87197B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2686899B1 (fr) 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
DE19535571A1 (de) * 1995-09-14 1997-03-20 Boehringer Mannheim Gmbh Pharmazeutische Kombinationspräparate und deren Verwendung zur Behandlung von Hämodialysepatienten
CA2239808A1 (en) * 1995-12-21 1997-06-26 Antonio Tiongson Direct compression carbonyl iron tablet
US5952226A (en) * 1996-11-05 1999-09-14 Modex Therapeutiques Hypoxia responsive EPO producing cells
DK0977582T3 (da) * 1997-03-18 2002-12-16 Roche Diagnostics Gmbh Farmaceutiske kombinationspræparater, der indeholder erythropoietin og jernpræparater
US7033774B2 (en) * 1997-04-21 2006-04-25 Glycozyme, Inc. Determination of recombinant glycosylated proteins and peptides in biological fluids
EP0885613A1 (de) * 1997-06-21 1998-12-23 Roche Diagnostics GmbH Verwendung von modifizierten Hämoglobinen zur Behandlung von Anämien und Kombinationspräparate umfassend Erythropoietin und modifiziertes Hämoglobin
JP2002509077A (ja) * 1998-02-09 2002-03-26 ユニヴァースティ オブ サザーン カリフォルニア 赤血球形成促進方法
US7304150B1 (en) * 1998-10-23 2007-12-04 Amgen Inc. Methods and compositions for the prevention and treatment of anemia
KR20020008186A (ko) 1999-05-11 2002-01-29 다우 케네드 제이. 에리트로포이에틴 투여의 약동학 및 약역학 모델링
US7459435B2 (en) 2002-08-29 2008-12-02 Hoffmann-La Roche Inc. Treatment of disturbances of iron distribution
DE10249552A1 (de) 2002-10-23 2004-05-13 Vifor (International) Ag Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel
US7459436B2 (en) 2002-11-22 2008-12-02 Hoffmann-La Roche Inc. Treatment of disturbances of iron distribution
AU2007205167B2 (en) 2006-01-06 2013-06-13 Vifor (International) Ag Methods and compositions for administration of iron

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57149228A (en) * 1981-03-11 1982-09-14 Ajinomoto Co Inc Novel erythropoietin and its preparation
US4732889A (en) * 1985-02-06 1988-03-22 Chugai Seiyaku Kabushiki Kaisha Pharmaceutical composition for the treatment of the anemia of rheumatoid arthritis
US4745099A (en) * 1985-02-06 1988-05-17 Chugai Seiyaku Kabushiki Kaisha Pharmaceutical composition for the treatment of the anemia of malignant tumors
JPS6231A (ja) * 1985-02-06 1987-01-06 Chugai Pharmaceut Co Ltd 腎性貧血治療剤
GB2177914B (en) * 1985-06-04 1989-10-25 Chugai Pharmaceutical Co Ltd A pharmaceutical composition containing human erythropoietin and a surface active agent for nasal administration for the treatment of anemia
US5013718A (en) * 1986-11-21 1991-05-07 Amgen, Inc. Method for treating iron overload using EPO
JPS63227527A (ja) * 1987-03-05 1988-09-21 キリン―アムジエン（デラウエア）インコーポレーテツド 貧血予防薬

Also Published As

Publication number Publication date
ATE70978T1 (de) 1992-01-15
DK194288A (da) 1988-10-11
GR3004071T3 (no) 1993-03-31
JP2858752B2 (ja) 1999-02-17
KR880012235A (ko) 1988-11-26
EP0286439B1 (en) 1992-01-02
US5541158A (en) 1996-07-30
DK167903B1 (da) 1994-01-03
PT87197B (pt) 1992-07-31
IE881064L (en) 1988-10-09
DK194288D0 (da) 1988-04-08
EP0286439A1 (en) 1988-10-12
PT87197A (pt) 1988-05-01
JPS63277630A (ja) 1988-11-15
AU1444588A (en) 1988-10-13
IE61008B1 (en) 1994-09-07
ES2035279T3 (es) 1995-04-01
AU613905B2 (en) 1991-08-15
DE3867285D1 (de) 1992-02-13

Similar Documents

Publication Publication Date Title
NO881507D0 (no) Fremgangsmaate for forhoeyning av hematokritnivaaet til et normalt pattedyr.
GR3003254T3 (en) Method for treating iron overload
DK238588A (da) Anvendelse af 3-(trifluormethylphenoxy)-n-methyl-3-phenylpropylamin til fremstilling af et laegemiddel til behandling af diabetes
ATE82860T1 (de) Thrombolytisches agens.
IT1215332B (it) Composizione farmaceutica contenente sulglicotide per la terapia dell'ulcera gastrica
JPS5229049A (en) Doorway for eleator
ATE74757T1 (de) Phenol enthaltende, fluessige antitussivzusammensetzungen.
EP0319962A3 (en) Piperidinyl methanol derivatives for the treatment of anxiety
IL88513A0 (en) D1-5-((2-benzyl-3',4-dihydro-2h-benzopyran-6-yl)methyl)thiazolidine-2',4-dione as an anti-atherosclerosis agent
DE3764235D1 (de) Ifosfamid-lyophilisat und verfahren zu dessen herstellung.
OA07728A (fr) Dérivés de l'acide bicyclo (3.2.1.) octane carboxylique, leur procédé de préparation et leur application thérapeutique.
IT8868103A0 (it) Procedimento per la rigenerazione di un additivo utilizzato per controllare le emissioni durante la combustione di combustibile ad elevato tenore di zolfo
NO852741L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 5,6-dihydro-4h-cyklopenta (b)tiofen-6-karboksylsyre-derivater
EP0351017A3 (en) Pharmaceutical composition useful for the treatment of cardiovascular diseases
JPS5218614A (en) Method of connecting right above elevated track to existing track
ZA872204B (en) Etodolac for use in lowering uric acid blood levels
PT87064A (pt) Process for the preparation of 5-hydroxydiprafenone and its acid addition salts
JPS549286A (en) Optical active isocarbostyryl derivatives and process for their preparation
JPS5246067A (en) Reduction of optically active 5-oxo-2-pyrrolidinacetic acid esters
JPS5412319A (en) Racemization of optically active lysine ester
BE905595A (fr) Procédé pour la préparation d'esters.
JPS52106843A (en) Cyclopentanone derivatives and their preparation
ES284303U (es) Capazo-cuna para coches-silla infantiles
JPS5382760A (en) Novel benzoylphenoxyacetic acid derivs., process for their preparation and lipid lowering agents contg. active constituents
IT8026007A0 (it) Esteri dell'eburnamina eprocedimento per la loro preparazione.